Geode Capital Management’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-1,060,417
| Closed | -$40.7M | – | 4852 |
|
|
2023
Q2 | $40.7M | Buy |
1,060,417
+111,866
| +12% | +$4.3M | ﹤0.01% | 1389 |
|
|
2023
Q1 | $22M | Buy |
948,551
+34,325
| +4% | +$795K | ﹤0.01% | 1735 |
|
|
2022
Q4 | $24M | Buy |
914,226
+39,669
| +5% | +$1.04M | ﹤0.01% | 1653 |
|
|
2022
Q3 | $17.2M | Buy |
874,557
+44,483
| +5% | +$874K | ﹤0.01% | 1848 |
|
|
2022
Q2 | $14.5M | Buy |
830,074
+53,008
| +7% | +$927K | ﹤0.01% | 1991 |
|
|
2022
Q1 | $12.7M | Buy |
777,066
+43,409
| +6% | +$710K | ﹤0.01% | 2183 |
|
|
2021
Q4 | $12M | Buy |
733,657
+113,888
| +18% | +$1.86M | ﹤0.01% | 2330 |
|
|
2021
Q3 | $7.91M | Buy |
619,769
+1,063
| +0.2% | +$13.6K | ﹤0.01% | 2637 |
|
|
2021
Q2 | $8.74M | Buy |
618,706
+172,669
| +39% | +$2.44M | ﹤0.01% | 2554 |
|
|
2021
Q1 | $6.93M | Buy |
446,037
+35,817
| +9% | +$557K | ﹤0.01% | 2609 |
|
|
2020
Q4 | $6.51M | Buy |
410,220
+229,629
| +127% | +$3.64M | ﹤0.01% | 2449 |
|
|
2020
Q3 | $2.19M | Sell |
180,591
-2,151
| -1% | -$26.1K | ﹤0.01% | 2832 |
|
|
2020
Q2 | $2.11M | Buy |
182,742
+1,341
| +0.7% | +$15.5K | ﹤0.01% | 2808 |
|
|
2020
Q1 | $2.49M | Buy |
181,401
+7,864
| +5% | +$108K | ﹤0.01% | 2565 |
|
|
2019
Q4 | $1.02M | Buy |
173,537
+20,961
| +14% | +$124K | ﹤0.01% | 3271 |
|
|
2019
Q3 | $808K | Buy |
152,576
+441
| +0.3% | +$2.34K | ﹤0.01% | 3307 |
|
|
2019
Q2 | $1.17M | Buy |
152,135
+7,325
| +5% | +$56.4K | ﹤0.01% | 3187 |
|
|
2019
Q1 | $2.88M | Buy |
144,810
+19,331
| +15% | +$385K | ﹤0.01% | 2629 |
|
|
2018
Q4 | $1.66M | Buy |
125,479
+12,689
| +11% | +$167K | ﹤0.01% | 2866 |
|
|
2018
Q3 | $4.15M | Buy |
112,790
+12,525
| +12% | +$460K | ﹤0.01% | 2468 |
|
|
2018
Q2 | $3.51M | Buy |
100,265
+19,477
| +24% | +$682K | ﹤0.01% | 2534 |
|
|
2018
Q1 | $3.76M | Buy |
80,788
+9,657
| +14% | +$449K | ﹤0.01% | 2419 |
|
|
2017
Q4 | $2.67M | Buy |
71,131
+7,872
| +12% | +$295K | ﹤0.01% | 2603 |
|
|
2017
Q3 | $3.37M | Buy |
63,259
+4,975
| +9% | +$265K | ﹤0.01% | 2442 |
|
|
2017
Q2 | $3.32M | Buy |
58,284
+5,722
| +11% | +$326K | ﹤0.01% | 2429 |
|
|
2017
Q1 | $2.83M | Buy |
52,562
+2,989
| +6% | +$161K | ﹤0.01% | 2458 |
|
|
2016
Q4 | $2.83M | Buy |
49,573
+5,094
| +11% | +$290K | ﹤0.01% | 2427 |
|
|
2016
Q3 | $2.76M | Buy |
44,479
+11,848
| +36% | +$736K | ﹤0.01% | 2355 |
|
|
2016
Q2 | $1.84M | Buy |
32,631
+16,042
| +97% | +$907K | ﹤0.01% | 2534 |
|
|
2016
Q1 | $1.06K | Buy |
16,589
+804
| +5% | +$51 | ﹤0.01% | 2848 |
|
|
2015
Q4 | $2.22M | Buy |
15,785
+277
| +2% | +$39K | ﹤0.01% | 2409 |
|
|
2015
Q3 | $1.5M | Buy |
+15,508
| New | +$1.5M | ﹤0.01% | 2626 |
|